Rahul Parikh
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer (NCT03762161) | Rahul Parikh | 2019-01-03 |
Track Rahul Parikh automatically
Every clearance here is in the API, with alerts when new ones post.